


SATOR Therapeutics Revenue
Pharmaceutical Manufacturing • Cleveland, Ohio, United States • 1-10 Employees
SATOR Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at SATOR Therapeutics
Anton Komar
Chief Technology Officer; acting CEO (Aug 2020- Oct 2023)
Company overview
| Headquarters | Cleveland, Ohio, United States |
| Website | |
| NAICS | 3254 |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
About SATOR Therapeutics
We are an oncology company that is focused on the development of oncolytic viruses that are able to selectively kill cancer cells and secondarily illicit a natural immune response. SATOR Therapeutics has developed a library of 30 oncolytic viruses which have demonstrated a differential response across multiple cancers where several viruses have shown efficacy across multiple indications. The viruses are non-engineered, non-pathogenic and can be administered systemically via IV. These viruses were collected over decades of research and by combining them can overcome many of the challenges associated with a single oncolytic virus and neutralizing antibodies while avoiding the safety problems associated with engineered viruses. Additionally, SATOR has developed a diagnostic approach for predicting efficacy as well as a next-generation delivery approach using dendritic cells.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
SATOR Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
SATOR Therapeutics has never raised funding before.
SATOR Therapeutics Tech Stack
Discover the technologies and tools that power SATOR Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Performance
Frequently asked questions
4.8
40,000 users



